| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | rRNA (cytosine-N4-)-methyltransferase activity | 2.81e-06 | 2 | 34 | 2 | GO:0071424 | |
| GeneOntologyMolecularFunction | rRNA (cytosine) methyltransferase activity | 4.20e-05 | 6 | 34 | 2 | GO:0016434 | |
| Domain | cNMP | 1.45e-03 | 34 | 31 | 2 | SM00100 | |
| Domain | cNMP_binding | 1.45e-03 | 34 | 31 | 2 | PF00027 | |
| Domain | cNMP-bd_dom | 1.53e-03 | 35 | 31 | 2 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 1.53e-03 | 35 | 31 | 2 | PS50042 | |
| Domain | cNMP-bd-like | 1.81e-03 | 38 | 31 | 2 | IPR018490 | |
| Domain | Kinase-like_dom | 1.84e-03 | 542 | 31 | 5 | IPR011009 | |
| Domain | - | 2.87e-03 | 48 | 31 | 2 | 2.60.120.10 | |
| Domain | RmlC-like_jellyroll | 3.23e-03 | 51 | 31 | 2 | IPR014710 | |
| Domain | Prot_kinase_dom | 8.34e-03 | 489 | 31 | 4 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 8.58e-03 | 493 | 31 | 4 | PS50011 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 32573735 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 35682734 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.32e-06 | 220 | 34 | 5 | 35785414 | |
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 9531570 | ||
| Pubmed | The Transcription Factor PLZF Is Necessary for the Development and Function of Mouse Basophils. | 2.78e-06 | 3 | 34 | 2 | 31366712 | |
| Pubmed | 5.56e-06 | 4 | 34 | 2 | 16024608 | ||
| Pubmed | Characterization and comparison of four serine- and arginine-rich (SR) protein kinases. | 5.56e-06 | 4 | 34 | 2 | 9307018 | |
| Pubmed | A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage. | 9.26e-06 | 5 | 34 | 2 | 27668799 | |
| Pubmed | Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors. | 9.26e-06 | 5 | 34 | 2 | 11865059 | |
| Pubmed | 9.26e-06 | 5 | 34 | 2 | 19168442 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.25e-05 | 146 | 34 | 4 | 23892456 | |
| Pubmed | 1.39e-05 | 6 | 34 | 2 | 32679061 | ||
| Pubmed | 1.39e-05 | 6 | 34 | 2 | 12460926 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 1.67e-05 | 861 | 34 | 7 | 36931259 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.94e-05 | 341 | 34 | 5 | 32971831 | |
| Pubmed | 3.33e-05 | 9 | 34 | 2 | 24821727 | ||
| Pubmed | DNA cross-link repair safeguards genomic stability during premeiotic germ cell development. | 3.33e-05 | 9 | 34 | 2 | 31367016 | |
| Pubmed | 4.15e-05 | 10 | 34 | 2 | 12738788 | ||
| Pubmed | 5.07e-05 | 11 | 34 | 2 | 33627187 | ||
| Pubmed | 5.93e-05 | 1442 | 34 | 8 | 35575683 | ||
| Pubmed | 7.19e-05 | 13 | 34 | 2 | 18986647 | ||
| Pubmed | PRSS50 is a testis protease responsible for proper sperm tail formation and function. | 8.38e-05 | 14 | 34 | 2 | 33913480 | |
| Pubmed | The histone deacetylase 9 gene encodes multiple protein isoforms. | 8.38e-05 | 14 | 34 | 2 | 12590135 | |
| Pubmed | DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. | 9.15e-05 | 89 | 34 | 3 | 22446626 | |
| Pubmed | 1.04e-04 | 251 | 34 | 4 | 28077445 | ||
| Pubmed | 1.57e-04 | 19 | 34 | 2 | 19474196 | ||
| Pubmed | 2.07e-04 | 1285 | 34 | 7 | 35914814 | ||
| Pubmed | 3.08e-04 | 1371 | 34 | 7 | 36244648 | ||
| Pubmed | Control of developmentally primed erythroid genes by combinatorial co-repressor actions. | 3.97e-04 | 30 | 34 | 2 | 26593974 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 4.54e-04 | 370 | 34 | 4 | 22922362 | |
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 6.05e-04 | 37 | 34 | 2 | 27565344 | |
| Pubmed | 6.07e-04 | 713 | 34 | 5 | 29802200 | ||
| Pubmed | 7.23e-04 | 419 | 34 | 4 | 15635413 | ||
| Pubmed | 7.79e-04 | 42 | 34 | 2 | 35705031 | ||
| GeneFamily | CDC like kinases | 9.27e-06 | 4 | 23 | 2 | 480 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-06 | 161 | 34 | 4 | 334f540dff3508d451e5e85e8e4e8f3b8d6b74e7 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-06 | 161 | 34 | 4 | 81d44438e4be4e68a59247e62f02026301a8a0c5 | |
| ToppCell | Healthy_donor-NK_CD56bright|Healthy_donor / disease group, cell group and cell class (v2) | 1.27e-05 | 189 | 34 | 4 | 9eac380a3bb4b685effb52d816e1960972660646 | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.55e-05 | 199 | 34 | 4 | 5f67ea58512856cbdcef759088a5869720a947a8 | |
| ToppCell | tumor_Lung-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.86e-04 | 146 | 34 | 3 | 8b2d104fdb0fdb09410450c6c651e1edb00cae44 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK-NK_CD56bright_CD16-|Lung / Manually curated celltypes from each tissue | 2.39e-04 | 159 | 34 | 3 | 595643e9433265308e5aab7f906229025701cf6a | |
| ToppCell | Influenza_Severe-Neutrophil|Influenza_Severe / Disease group and Cell class | 2.48e-04 | 161 | 34 | 3 | 98c95b1b85d5427415af2ca8fb14849e97f6e8b5 | |
| ToppCell | Influenza_Severe-NK_CD56bright|Influenza_Severe / Disease group and Cell class | 2.57e-04 | 163 | 34 | 3 | 7748d5709e8cf6673f5a8370108309f76cd830f4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-04 | 164 | 34 | 3 | f6a961fa2002da7d9679f32af99e1314c0593ef9 | |
| ToppCell | Healthy-NK_CD56bright|Healthy / disease group, cell group and cell class | 2.62e-04 | 164 | 34 | 3 | ed193211965accba60a256d3e6c159f0fc911d8b | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.76e-04 | 167 | 34 | 3 | 94642b3dae035fedb6e8b9745f440096a4539f3c | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.76e-04 | 167 | 34 | 3 | 42b299273a6c72a625b204d55f4f3c4eebd6d185 | |
| ToppCell | Healthy-NK_CD56bright|World / disease group, cell group and cell class | 2.76e-04 | 167 | 34 | 3 | ab7a570a75ee2018b9fe886cdec79cda27f1563f | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.76e-04 | 167 | 34 | 3 | ecf5bc634e1e01efd783617eb81d1704e903ea21 | |
| ToppCell | Influenza_Severe-Neutrophil|World / Disease group and Cell class | 2.86e-04 | 169 | 34 | 3 | 6e8e2580e19c96bcf7fa6a6d8c183df65f428396 | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.01e-04 | 172 | 34 | 3 | 980e8b9e1ceeb0dec9eb9ef95c139e5ffe99b6e4 | |
| ToppCell | severe_influenza-Neutrophil|severe_influenza / disease group, cell group and cell class (v2) | 3.06e-04 | 173 | 34 | 3 | 615e266419b9f06e964eff73cb466f05451ba0dd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-04 | 174 | 34 | 3 | 46bd0ef7d0541386de7a901d85d53d0176dc92bf | |
| ToppCell | IPF-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 3.17e-04 | 175 | 34 | 3 | b6d1e40d9339426d778481fd67ab7cbc0f6cb5b2 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.17e-04 | 175 | 34 | 3 | cc2428150987911d0d382e8177918724aa69f85c | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-T_mait-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.27e-04 | 177 | 34 | 3 | 605f71515c877bb4de4121675ec8c1318a2500a7 | |
| ToppCell | 21-Trachea-Immune-Hematopoietic,_Natural_Killer_Cell|Trachea / Age, Tissue, Lineage and Cell class | 3.33e-04 | 178 | 34 | 3 | d2e1f6b7933b7da2682393e5ff5e03cdd8f64761 | |
| ToppCell | Control-T/NK-NK|Control / Disease group,lineage and cell class (2021.01.30) | 3.33e-04 | 178 | 34 | 3 | 079fd19bdeed86bf985c4083af432432d66ad546 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK-ILC_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.38e-04 | 179 | 34 | 3 | d18a520568cf4b031972d3dd7d4d4bd073ac1fea | |
| ToppCell | Severe-B_naive-12|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.44e-04 | 180 | 34 | 3 | bc20e581d37cba72b71ef62df60475a0ccee9994 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.50e-04 | 181 | 34 | 3 | 274c0b768925cd5804483303f8c5ebd17a534c41 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.61e-04 | 183 | 34 | 3 | 3ef9ac1ae13b6172f9121ab1c129ecaa0fef460f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 3.73e-04 | 185 | 34 | 3 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.73e-04 | 185 | 34 | 3 | e8f7da9641b6cf1db1093b4f301ce828fd3a529c | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_bright-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.73e-04 | 185 | 34 | 3 | 3b2da51aec057b462749ae39afb8f253afcf38d5 | |
| ToppCell | IIH-NK|IIH / Condition, Cell_class and T cell subcluster | 3.79e-04 | 186 | 34 | 3 | cab1249b849013cf0334f25ee8d840f0521f4eb8 | |
| ToppCell | IIH-NK-|IIH / Condition, Cell_class and T cell subcluster | 3.79e-04 | 186 | 34 | 3 | 2c90b45c8ccfd86bbf6840dba7f0d7f08b5ea914 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.79e-04 | 186 | 34 | 3 | de55471dd5c842026b409cfebf67fe32f079a011 | |
| ToppCell | Influenza-Influenza_Severe-Myeloid-Neutrophil|Influenza_Severe / Disease, condition lineage and cell class | 3.79e-04 | 186 | 34 | 3 | 1dfcec9196d4db76fba3abc74e85885b1fb98b87 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-04 | 188 | 34 | 3 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.91e-04 | 188 | 34 | 3 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | Healthy_donor-NK_CD56bright|World / disease group, cell group and cell class (v2) | 3.91e-04 | 188 | 34 | 3 | 8ee359199c61c3b5b498ac35148390db5cc1a836 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-NK_CD56bright_CD16-|bone_marrow / Manually curated celltypes from each tissue | 3.97e-04 | 189 | 34 | 3 | 6e402fb3fc31e4cb541e3cd140d7a86c1083dbf5 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.03e-04 | 190 | 34 | 3 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | Severe-MAIT|World / Disease group and Cell class | 4.03e-04 | 190 | 34 | 3 | 7a92e0d6a021be23125495927b8571e25c83204a | |
| ToppCell | Severe-MAIT|Severe / Disease group and Cell class | 4.03e-04 | 190 | 34 | 3 | 1c063dc1b62d9f9912aaf8d0297555a6545f5550 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.09e-04 | 191 | 34 | 3 | 7a4fe96989f72159385270c712342ba3e1ca6fc3 | |
| ToppCell | Control-Lymphoid_T/NK-NK_CD56bright|Control / Disease group, lineage and cell class | 4.09e-04 | 191 | 34 | 3 | e842f29bc03ed6734b2a7b975e7830a498f2743c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.09e-04 | 191 | 34 | 3 | f1935e8f8467a2bc30588b7f2cc3b94e9c83b268 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.09e-04 | 191 | 34 | 3 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.09e-04 | 191 | 34 | 3 | c023ca893ceae19b54967096f6e2588dc39fa268 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.09e-04 | 191 | 34 | 3 | 1161e465c50c2071764279e01cf08b1048cce0e3 | |
| ToppCell | COVID-19-kidney-Myeloid|kidney / Disease (COVID-19 only), tissue and cell type | 4.15e-04 | 192 | 34 | 3 | 441cd1ec171f643b28e1f6f9c04def629cc7391b | |
| ToppCell | COVID-19-Myeloid-MoAM1,_IL1R2|Myeloid / Condition, Lineage and Cell class | 4.15e-04 | 192 | 34 | 3 | be9d5685fa03563322f147a4b38ed31e4da59487 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-NK|normal_Pleural_Fluid / Location, Cell class and cell subclass | 4.15e-04 | 192 | 34 | 3 | 59dd4f5ae9f1cca78adf60b71661092ef09e6641 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-04 | 192 | 34 | 3 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | T/NK_cells-CD56bright_NK_cell|World / Lineage and Cell class | 4.15e-04 | 192 | 34 | 3 | 528b5b790a0e8966d04ffbc83b049c93bac17537 | |
| ToppCell | droplet-Thymus-nan-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-04 | 193 | 34 | 3 | 81871f4f2b63ca5f64a9ff12f6c909a34bf52216 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-04 | 193 | 34 | 3 | 12380713db6582749183a19de65d4af9d6469a3f | |
| ToppCell | Mild_COVID-19-T/NK-NK|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 4.22e-04 | 193 | 34 | 3 | 9c455d9d845fa230e9a61d9a5f9d6a2ccf5d7350 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-04 | 193 | 34 | 3 | 2483bb7f398e4fa0ef09c8bd584ed25703853f03 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-NK|ICU-SEP / Disease, Lineage and Cell Type | 4.22e-04 | 193 | 34 | 3 | f110f86db305e41639087f5b1a2dff103c07adf0 | |
| ToppCell | Control-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 4.22e-04 | 193 | 34 | 3 | 3479c01aaae7afd7e02d00e0cb21951c0106a0fd | |
| ToppCell | ILEUM-inflamed-(6)_ILC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.28e-04 | 194 | 34 | 3 | 4d51d49366c34ff1241770b4acc0167a43b3155a | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-04 | 194 | 34 | 3 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-NK_CD56bright_CD16-|bone_marrow / Manually curated celltypes from each tissue | 4.28e-04 | 194 | 34 | 3 | 5c58a2d1dd3c8ff77ce44d473239685e6b020909 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-04 | 194 | 34 | 3 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | BLOOD--(0)_NK_cells_(CD56bright-like)| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.28e-04 | 194 | 34 | 3 | 8d4368d546bba17a420e172bfb5f1f337fe23c44 | |
| ToppCell | T/NK_cells-CD56bright_NK_cell|T/NK_cells / Lineage and Cell class | 4.35e-04 | 195 | 34 | 3 | d2c8f5c114b1864b509fad449aa4492dfc61113c | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.35e-04 | 195 | 34 | 3 | 609732e83ab7fc3ba7dace66f5a17e46557fd6d1 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.35e-04 | 195 | 34 | 3 | acc603dc94ac6518adb0dffb43305b380ec75b52 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-NK_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.35e-04 | 195 | 34 | 3 | 4eb13aa9fc496caca6e0a4fb80d11a60cf2511b0 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-NK_cell-NK-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.35e-04 | 195 | 34 | 3 | 234666fb7a1fd7e33bb7e54fd4004649ce22de70 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-NK_cell-NK|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.35e-04 | 195 | 34 | 3 | 90c77b7f245b1bf80ba293583f8fe343b14c7f67 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-04 | 195 | 34 | 3 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.35e-04 | 195 | 34 | 3 | 72f42f0be53a2a61f61647118b4883e752d998a5 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-NK_cell-NK|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.35e-04 | 195 | 34 | 3 | f0fb039f3d2e36acb258afb8b6d2fed20c395c36 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-NK_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.35e-04 | 195 | 34 | 3 | c7743d8c57584d29cca69c6405f1df6718174582 | |
| ToppCell | Control-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class | 4.35e-04 | 195 | 34 | 3 | fcb05948e7480dc53f06f3fc9b9c3fc129874edd | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-04 | 195 | 34 | 3 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-NK_cell-NK-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.35e-04 | 195 | 34 | 3 | 89d832d1715f2720caa8cdd1e7ef847d79642556 | |
| ToppCell | normal-na-Lymphocytic_NK|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.35e-04 | 195 | 34 | 3 | cebe79c42af5910353ba9ad7d0edb01982f772a3 | |
| ToppCell | COVID-19_Severe-PLT_4|World / Disease Group and Platelet Clusters | 4.41e-04 | 196 | 34 | 3 | ad43efdd4d73b6615f65f06a315b33576e317473 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-NK|normal_Lymph_Node / Location, Cell class and cell subclass | 4.41e-04 | 196 | 34 | 3 | 00ab4a1547752d419aa720b39b94a4ab2ede963a | |
| ToppCell | 3'-Distal_airway-Endothelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.48e-04 | 197 | 34 | 3 | 9ffb823c0f3f23cc85f9fd3ca24f77817e90bd86 | |
| ToppCell | VE-NK|VE / Condition, Cell_class and T cell subcluster | 4.48e-04 | 197 | 34 | 3 | cae6ff8763501e7a5897b50188ac2640d65a47c0 | |
| ToppCell | lymphoid-T_cell-Regulatory_T_cell|lymphoid / Lineage, cell class and subclass | 4.48e-04 | 197 | 34 | 3 | 73d5dcf076caae60ea32258b4e9dcac8979a661e | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.48e-04 | 197 | 34 | 3 | ca6bce1a92c6326f41a6300c31da02386bafa152 | |
| ToppCell | VE-NK-|VE / Condition, Cell_class and T cell subcluster | 4.48e-04 | 197 | 34 | 3 | ee89b8521fb4faaed9e4d39f7171e45eccf38b00 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.48e-04 | 197 | 34 | 3 | 6ac8d3e3f573e3848ab33e4df66dfaf8f948ea6c | |
| ToppCell | normal-na-Lymphocytic_NK-natural_killer_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.48e-04 | 197 | 34 | 3 | 73a33d8b27043ba3074d04bc2d18cd287e00117f | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-Activated_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.48e-04 | 197 | 34 | 3 | dfec2afd1cbe218c9234ce7d4b5a5839b268398d | |
| ToppCell | normal-na-Lymphocytic_NK-natural_killer_cell-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.48e-04 | 197 | 34 | 3 | 994d3289a5dd1a89fbcf28a6263e3784ccf732df | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.48e-04 | 197 | 34 | 3 | e3be7758a92f12e0a423394822957e1b7f995110 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.54e-04 | 198 | 34 | 3 | 5eedcc20e35adbabe268a93b748ee4566b3ffb66 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.54e-04 | 198 | 34 | 3 | 3aae7d146ebbb34da3239041a7c0334abff2597f | |
| ToppCell | Severe-Lymphoid-NK|Severe / Condition, Lineage, Cell class and cell subclass | 4.54e-04 | 198 | 34 | 3 | 26b6d20527d22ce68067cdaea6b4330cb779f91b | |
| ToppCell | COVID-19_Severe-PLT_4|COVID-19_Severe / Disease Group and Platelet Clusters | 4.54e-04 | 198 | 34 | 3 | abfddbee99ef8c7719e6e6f62571e9be030e4acf | |
| ToppCell | lymphoid-T_cell-Regulatory_T_cell|T_cell / Lineage, cell class and subclass | 4.54e-04 | 198 | 34 | 3 | 6773c6043ef4a3d9e9700330b6386431ee66abdc | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.54e-04 | 198 | 34 | 3 | 2400f8b8c51739ea2ae2b9f24f44eaeefa2bb6fc | |
| ToppCell | distal-1-Endothelial-Capillary|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.61e-04 | 199 | 34 | 3 | 4b22769882fdd83f9cdca59e4d39ef441e62856b | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-NK_CD56bright|Influenza_Severe / Disease, condition lineage and cell class | 4.61e-04 | 199 | 34 | 3 | 784e7e7ede2baa28ede600834813e6de2240bfdf | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.61e-04 | 199 | 34 | 3 | 8db1acdcabf97f01b9ca17456c48ec8ac4928390 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.61e-04 | 199 | 34 | 3 | 6cfe5a3d0ad530411ebc11decb4ab4c529e018d5 | |
| ToppCell | Sigmoid-(3)_ILC|Sigmoid / shred on region, Cell_type, and subtype | 4.68e-04 | 200 | 34 | 3 | a7326c43987a5eb4f4f5b48c4252cf4870432e5d | |
| Disease | neutrophil measurement | 5.04e-05 | 177 | 34 | 4 | EFO_0803548 | |
| Disease | anxiety disorder (implicated_via_orthology) | 2.93e-04 | 22 | 34 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | triacylglycerol 54:3 measurement | 5.87e-04 | 31 | 34 | 2 | EFO_0010421 | |
| Disease | Gastric Adenocarcinoma | 1.24e-03 | 45 | 34 | 2 | C0278701 | |
| Disease | HOMA-B | 1.84e-03 | 55 | 34 | 2 | EFO_0004469 | |
| Disease | coronary artery disease | 2.20e-03 | 1194 | 34 | 6 | EFO_0001645 | |
| Disease | thyroxine measurement | 4.14e-03 | 83 | 34 | 2 | EFO_0005130 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VGHMPVMVAKQQEFK | 881 | O15013 | |
| IMIQKHKADMGVNVG | 86 | Q9BYG8 | |
| EEKEEEMVVLVVMGG | 121 | A0A3B3IU63 | |
| KHVKAEMEQMALDVG | 1006 | O95477 | |
| THMEKDMVELGKVQE | 816 | A2A2Z9 | |
| ENREHLVMMEKILGP | 526 | P49761 | |
| IGELKAVMEGIKMEH | 646 | Q9UDT6 | |
| AVMEGIKMEHQLELG | 651 | Q9UDT6 | |
| EGTEKEEIMVQGMPQ | 3911 | Q01484 | |
| IHEEKEMRIMTPEGK | 261 | Q13478 | |
| MLKEEQEVAMLGVPH | 21 | Q01629 | |
| HIIPVKNQEGVAMMF | 111 | Q9NS40 | |
| VKEMVMGLNVLDPHT | 1366 | Q7LBC6 | |
| VMQVVGHKEGLDVME | 121 | Q9NX47 | |
| AEEENPEHVEIQKMM | 486 | O00566 | |
| ETMAKLHIPVMVDEV | 66 | P0C7V9 | |
| DMGFEPDVQKILEHM | 556 | Q9BUQ8 | |
| ETMAKLHIPVMVDEV | 66 | A6NJ78 | |
| AMVEKMHELVGGVPQ | 226 | Q8WW52 | |
| IHMVDNGIVEKLMDL | 351 | P52306 | |
| MDGMHVAVKIVKNVG | 181 | Q9HAZ1 | |
| MHEVKGKDGVGAVMD | 76 | Q96RP9 | |
| DKVMEVKGQMIHVPE | 401 | P33402 | |
| IPEHMVRGSKIMEAE | 226 | Q9Y2M0 | |
| DMEIIELKEMGSQPH | 556 | Q8IWB6 | |
| DDKVEDHGVVMSQPM | 2276 | O75376 | |
| IQEMEMGVKQPHQMV | 931 | Q9P2P6 | |
| LMVDVPGHGKVMVDI | 171 | Q96EM0 | |
| NMQKVEEEGEIVMVK | 241 | Q9Y4G8 | |
| PGVAEVKTEMMQVDE | 236 | Q05516 | |
| TAVEMGMKNHEIVPG | 21 | Q9BVS4 | |
| VGVEKEVGGMEMAHE | 361 | Q9C0J8 | |
| TVIMEPHKEVLQDMV | 1276 | Q9Y4A5 | |
| MERMLHVVDGKVPDT | 116 | Q8NFA0 | |
| EGVTVDDHMMKVETV | 391 | Q5BKZ1 |